- $1.51bn
- $1.44bn
- $419.81m
- 82
- 15
- 97
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.71 | ||
| Price to Tang. Book | 13.99 | ||
| Price to Free Cashflow | 182.3 | ||
| Price to Sales | 3.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.17% | ||
| Return on Equity | -22.67% | ||
| Operating Margin | -13.84% | ||
Financial Summary
| Year End 31st Jan | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 148.68 | 213.23 | 280.91 | 356.3 | 419.81 | 476.13 | 532.72 | 27.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Directors
- Michael Weintraub NEC (62)
- Chaim Indig CEO (42)
- Randy Rasmussen CFO
- Evan Roberts COO (42)
- Michael Davidoff SVP (48)
- Amy VanDuyn SVP (48)
- Balaji Gandhi SVP
- David Linetsky SVP (41)
- Daniel Nathan CTO
- Allison Hoffman GCN (50)
- Ramin Sayar DRC (48)
- Edward Cahill IND (68)
- Lainie Goldstein IND (53)
- Gillian Munson IND (50)
- Mark Smith IND (69)
- Last Annual
- January 31st, 2025
- Last Interim
- January 31st, 2025
- Incorporated
- January 10th, 2005
- Public Since
- July 18th, 2019
- No. of Shareholders
- 37
- No. of Employees
- 2,082
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
New York Stock Exchange- Shares in Issue
- 58,772,448
- Address
- 1521 Concord Pike, Suite 301 Pmb 221, WILMINGTON, 19803
- Web
- https://www.phreesia.com
- Phone
- +1 6467479959
- Contact
- Balaji Gandhi
- Auditors
- KPMG LLP
Upcoming Events for PHR
Q1 2026 Phreesia Inc Earnings Call
Phreesia Inc Annual Shareholders Meeting
Q2 2026 Phreesia Inc Earnings Release
Similar to PHR
A10 Networks
New York Stock Exchange
Accenture
New York Stock Exchange
ACV Auctions
New York Stock Exchange
Alibaba Holding
New York Stock Exchange
Alight
New York Stock Exchange
FAQ
What is the Phreesia share price?
As of Today at 16:39 UTC, shares in Phreesia are trading at $25.72. This share price information is delayed by 15 minutes.
How has the Phreesia share price performed this year?
Shares in Phreesia last closed at $25.72 and the price had moved by +15.54% over the past 365 days. In terms of relative price strength the Phreesia share price has outperformed the S&P500 Index by +4.19% over the past year.
What are the analyst and broker recommendations for Phreesia?
The overall consensus recommendation for Phreesia is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Phreesia dividend yield?
Phreesia does not currently pay a dividend.
Does Phreesia pay a dividend?
Phreesia does not currently pay a dividend.
When does Phreesia next pay dividends?
Phreesia does not currently pay a dividend.
How do I buy Phreesia shares?
To buy shares in Phreesia you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Phreesia?
As of the previous close price of $25.72, shares in Phreesia had a market capitalisation of $1.51bn.
Where are Phreesia shares listed?
Here are the trading details for Phreesia:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: PHR
What kind of share is Phreesia?
Based on an overall assessment of its quality, value and momentum Phreesia is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Phreesia share price forecast for 2025?
The analyst consensus target price for shares in Phreesia is $32.27. That is 25.47% above the last closing price of $25.72.
Analysts covering Phreesia currently have a consensus Earnings Per Share (EPS) forecast of -$0.22 for the next financial year.
Find out moreWhat is the trend in the Phreesia share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Phreesia. Over the past six months, its share price has outperformed the S&P500 Index by +39.89%.
As of the last closing price of $25.72, shares in Phreesia were trading +6.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Phreesia PE Ratio?
The Phreesia PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $25.72.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Phreesia?
Phreesia's management team is headed by:
- Michael Weintraub - NEC
- Chaim Indig - CEO
- Randy Rasmussen - CFO
- Evan Roberts - COO
- Michael Davidoff - SVP
- Amy VanDuyn - SVP
- Balaji Gandhi - SVP
- David Linetsky - SVP
- Daniel Nathan - CTO
- Allison Hoffman - GCN
- Ramin Sayar - DRC
- Edward Cahill - IND
- Lainie Goldstein - IND
- Gillian Munson - IND
- Mark Smith - IND